Competition Law and Director Duties and Competition Compliance

1. Introduction

Competition compliance is not merely a responsibility of the legal or compliance department. Directors and senior management have an important governance responsibility to ensure that the company does not engage in conduct prohibited by competition law.

In India, this relationship is particularly important because two legal regimes operate together:

1. The Competition Act, 2002, which regulates anti-competitive agreements, abuse of dominant position and combinations; and
2. The Companies Act, 2013, particularly the statutory duties imposed on directors concerning good faith, due care, skill, diligence, independent judgment and avoidance of conflicts.

The Competition Act prohibits agreements that cause or are likely to cause an appreciable adverse effect on competition, including horizontal arrangements such as price-fixing, market allocation and bid-rigging.

The Supreme Court's decision in Excel Crop Care Ltd. v. Competition Commission of India demonstrates how seriously cartel conduct can be treated: the case concerned coordinated bidding in government tenders and resulted in substantial penalties against the participating companies.

2. Meaning of Competition Compliance

Competition compliance means the system adopted by an enterprise to prevent, detect and respond to conduct that violates competition law.

It normally includes:

• competition-law policies;
• employee and director training;
• controls over communications with competitors;
• procedures for trade-association participation;
• merger and acquisition review;
• monitoring of pricing practices;
• tender and procurement controls;
• dawn-raid/investigation protocols;
• whistle-blower mechanisms;
• internal investigations;
• document-retention policies; and
• disciplinary measures for employees who breach competition rules.

The central idea is prevention rather than merely responding to a CCI investigation.

3. Why Directors Have a Competition-Compliance Responsibility

A company acts through its officers, directors and employees. Consequently, competition violations frequently arise from decisions made by senior management.

Examples include:

• directors agreeing with competitors to maintain prices;
• executives allocating customers or geographical territories;
• management coordinating bids;
• sharing commercially sensitive information;
• imposing exclusionary contractual conditions;
• approving a potentially anti-competitive acquisition;
• instructing employees to communicate with competitors about future pricing.

Therefore, the board cannot reasonably treat competition compliance as an exclusively operational matter.

A board that establishes no compliance framework may expose the company to significant regulatory risk and may also create questions concerning whether directors properly discharged their statutory duties.

4. Competition Act, 2002 and Directors

A. Section 3 — Anti-competitive agreements

Section 3 is the primary provision concerning anti-competitive agreements.

Section 3(1) prohibits agreements relating to production, supply, distribution, storage, acquisition or control of goods or provision of services that cause or are likely to cause an appreciable adverse effect on competition (AAEC).

Section 3(3) is particularly important for directors because it addresses agreements between competitors.

Examples include:

• price fixing;
• limitation or control of production;
• market or customer allocation;
• bid-rigging;
• collusive tendering.

For directors, these are the highest-risk areas.

Example

Suppose Directors A and B are directors of competing pharmaceutical companies.

They agree informally:

Company A will quote ₹100 for Product X and Company B will quote ₹105, so that Company A wins the tender.

Even if there is no formal written agreement, communications, meetings and coordinated conduct may constitute evidence of concerted action.

5. Section 4 — Abuse of Dominant Position

Directors of dominant enterprises must exercise additional caution.

Section 4 prohibits abuse of a dominant position.

Potential abusive conduct includes:

• unfair or discriminatory conditions;
• unfair or discriminatory pricing;
• predatory pricing;
• denial of market access;
• tying or bundling;
• leveraging dominance from one market into another;
• exclusionary contractual practices.

Importantly, being dominant is not itself unlawful.

The unlawful conduct is the abuse of dominance.

Therefore, directors of a dominant enterprise should ensure that commercial strategies are examined from a competition perspective before implementation.

6. Section 5 and 6 — Mergers, Acquisitions and Directors

Competition compliance also becomes crucial when directors approve:

• mergers;
• acquisitions;
• amalgamations;
• joint ventures;
• acquisition of substantial assets;
• acquisition of voting rights or control.

A transaction can create or strengthen market power and may therefore require competition-law analysis.

Consequently, boards should not approve major transactions solely on the basis of financial or corporate-law considerations.

A proper board process should ask:

1. What is the relevant market?
2. What is the combined market position?
3. Are competitors being eliminated?
4. Are customers likely to lose alternatives?
5. Are there barriers to entry?
6. Does the transaction require notification?
7. Are behavioural or structural remedies necessary?

7. Section 48 — Liability of Persons in Charge of a Company

This is one of the most important provisions connecting competition law with director responsibility.

Section 48 deals with contraventions by companies.

Where a company commits a contravention, persons who were in charge of and responsible to the company for the conduct of its business may also become liable, subject to the statutory requirements and available defences.

This creates a major compliance lesson:

Directors should not assume that incorporation automatically protects individuals from competition-law consequences.

However, individual liability is not automatic merely because someone holds the title "director."

The factual question of responsibility, involvement and the statutory requirements under Section 48 are important.

8. Directors' Duties Under the Companies Act, 2013

Section 166 of the Companies Act, 2013 provides the principal statutory framework for directors' duties.

Among other things, directors must:

• act in accordance with the articles;
• act in good faith;
• promote the objects of the company;
• act in the best interests of the company;
• exercise due and reasonable care, skill and diligence;
• exercise independent judgment; and
• avoid situations involving direct or indirect conflicts of interest.

These duties have an important competition-law dimension.

For example

A director who knowingly authorises a cartel may potentially face questions not merely under competition law but also regarding whether the director properly discharged the statutory duty to act in the company's interests and exercise appropriate care and diligence.

9. Competition Compliance as Part of Corporate Governance

Modern corporate governance should therefore treat competition compliance as a board-level risk-management function.

A good governance structure may look like this:

Board of Directors

↓

Competition Compliance Committee / Audit Committee

↓

General Counsel / Compliance Officer

↓

Business Units

↓

Sales / Procurement / Marketing / Strategy Teams

↓

Employees and Agents

The board should establish a framework within which competition risks are identified before commercial decisions are implemented.

10. Six Major Case Laws

Case 1 — Excel Crop Care Ltd. v. Competition Commission of India

(2017) 8 SCC 47

Facts

The case concerned manufacturers of aluminium phosphide tablets participating in Food Corporation of India tenders.

The CCI found coordinated conduct amounting to anti-competitive behaviour and imposed penalties.

The Supreme Court ultimately considered both the competition violation and the proper approach to penalty.

The case involved allegations of coordinated bidding and conduct falling within Section 3(3).

Importance

The case establishes an important compliance principle:

Tender-related communications with competitors are extremely high-risk.

Directors should therefore ensure strict controls concerning:

• competitor contacts;
• tender pricing;
• bidding strategies;
• exchange of market information;
• participation in industry meetings.

Director-duty lesson

A director should ensure that employees responsible for tenders receive specific antitrust training.

Case 2 — Competition Commission of India v. Steel Authority of India Ltd.

(2010) 10 SCC 744

This is a foundational Supreme Court decision concerning the procedural architecture of Indian competition law.

The Supreme Court considered the nature of proceedings before the CCI and the significance of the Commission's initial decision to proceed with investigation.

Importance for directors

Directors should understand that once credible competition concerns arise, the matter can move into a formal investigative process.

Therefore, companies should have:

• investigation protocols;
• document-preservation mechanisms;
• authorised spokespersons;
• legal review procedures; and
• employee instructions concerning interaction with regulators.

Compliance lesson

Do not wait until a CCI investigation begins to create a competition-compliance programme.

Case 3 — Cadila Healthcare Ltd. v. Competition Commission of India

2018 SCC OnLine Del 11229

The Delhi High Court considered the scope of investigation by the Director General.

The Court relied upon the principles explained in Excel Crop Care and recognised that investigation may uncover broader competition concerns than the original information might initially suggest.

Importance

This is particularly significant for directors because an apparently narrow complaint may expose a broader pattern of conduct.

For example:

A complaint about one tender may reveal coordinated bidding across several tenders.

Director-duty lesson

Boards should therefore maintain comprehensive compliance systems rather than addressing only the specific conduct that has already attracted regulatory attention.

Case 4 — Rajasthan Cylinders & Containers Ltd. v. Union of India

(2018) 14 SCC 268

This Supreme Court decision dealt with allegations concerning cartelisation in the LPG cylinder market.

The Court considered whether the evidence established an anti-competitive agreement and the importance of demonstrating the statutory requirements for cartel liability.

Importance

The case illustrates that competition authorities must establish the necessary elements of a competition violation.

But from a compliance perspective, it also demonstrates the danger of coordinated behaviour among competitors.

Directors should be especially careful regarding:

• trade associations;
• meetings with competitors;
• price discussions;
• capacity discussions;
• future business strategies.

Case 5 — United States v. Apple Inc.

U.S. District Court, Southern District of New York, 2013

The Apple e-books litigation concerned allegations that Apple and major publishers coordinated in a manner that increased e-book prices.

The court found Apple liable for participating in an unlawful conspiracy.

Importance for directors

This case demonstrates that competition risk may arise through facilitation, not merely through a straightforward agreement between two competitors.

A senior executive may create significant competition risk by:

• facilitating communication;
• organising meetings;
• encouraging competitors to adopt similar commercial practices;
• acting as an intermediary.

Compliance lesson

Directors and senior executives should not assume:

"I did not personally agree on the final price, so there is no risk."

Facilitation itself can be legally significant.

Case 6 — United States v. American Airlines, Inc.

916 F.2d 1231 (5th Cir. 1990)

The case concerned allegations of coordination between American Airlines and Braniff involving competitive behaviour and signalling.

The case is important in understanding how communications between competitors can raise competition concerns even where the conduct is not reduced to a conventional written cartel agreement.

Compliance lesson

Directors should recognise that:

competition law focuses on substance and economic conduct, not merely formal contracts.

Emails, telephone calls, meetings, public statements and signalling can potentially become important evidence.

Case 7 — United States v. Socony-Vacuum Oil Co.

310 U.S. 150 (1940)

This is a classic U.S. Supreme Court authority on price fixing.

The Court treated agreements designed to influence or maintain prices as falling within the prohibition against unlawful price fixing.

Importance

The case remains important for understanding the fundamental principle that competitors cannot coordinate their pricing strategies simply because the arrangement may appear commercially convenient.

Director lesson

A board should never approve:

• competitor price coordination;
• customer allocation;
• output restrictions;
• coordinated bids.

11. Directors and Cartel Risk

Cartels represent the greatest competition-compliance risk.

A cartel can involve:

Price fixing

Competitors agree on:

• minimum prices;
• discounts;
• price increases;
• surcharges;
• pricing formulas.

Market allocation

Competitors divide:

• geographical areas;
• customers;
• product categories;
• government contracts.

Output restriction

Competitors coordinate:

• production volumes;
• supply quantities;
• capacity utilisation.

Bid rigging

Competitors decide:

• who will win;
• who will submit a cover bid;
• who will abstain;
• what price each bidder will submit.

The Excel Crop Care litigation is an especially useful Indian illustration of the risks associated with coordinated tender behaviour.

12. Directors and Exchange of Commercially Sensitive Information

Directors should be extremely cautious about information exchange with competitors.

Sensitive information may include:

• future prices;
• discounts;
• production plans;
• customer lists;
• sales forecasts;
• capacity;
• costs;
• margins;
• strategic plans;
• future product launches.

Even where competitors do not expressly agree to fix prices, systematic exchange of sensitive information can facilitate coordination.

Therefore:

"We only exchanged information" is not necessarily a complete competition-law defence.

13. Trade Associations and Directors

Trade associations are a common source of competition risk.

Directors attending industry meetings should avoid discussions about:

• future prices;
• discounts;
• customer allocation;
• production restrictions;
• commercial strategies;
• tenders;
• future competitive conduct.

A competition-compliance protocol should apply to all trade-association meetings.

Recommended rule

If competitors begin discussing pricing or market allocation:

1. immediately object;
2. request that the discussion stop;
3. leave the meeting if necessary;
4. ensure that the objection is recorded; and
5. notify the legal/compliance department.

14. Competition Compliance and Board Minutes

Board minutes are particularly important.

Minutes should demonstrate that directors considered competition risks where appropriate.

For example, in an acquisition:

"The Board considered the potential competition-law implications of the proposed transaction and instructed management to obtain appropriate competition-law advice before completion."

This demonstrates a governance process.

However, directors should avoid creating misleading or unnecessary statements.

The objective is accurate documentation of genuine compliance consideration, not creating paperwork merely to manufacture a defence.

15. Competition Compliance in M&A

Before approving a merger or acquisition, directors should consider:

Stage 1 — Preliminary screening

Determine:

• relevant markets;
• market shares;
• competitors;
• customer alternatives;
• barriers to entry.

Stage 2 — Competitive overlap

Identify whether the transaction is:

• horizontal;
• vertical;
• conglomerate.

Stage 3 — Regulatory analysis

Determine whether:

• notification is required;
• exemptions apply;
• remedies may be necessary.

Stage 4 — Due diligence

Review:

• pricing policies;
• competitor communications;
• distribution agreements;
• exclusivity clauses;
• rebates;
• loyalty schemes;
• previous competition complaints.

Stage 5 — Board approval

The board should receive adequate competition-law advice before approving the transaction.

16. Competition Compliance and Dominant Companies

Directors of dominant companies need particularly strong internal controls.

For example, a dominant digital platform should scrutinise:

• self-preferencing;
• tying;
• exclusivity;
• discriminatory access;
• interoperability restrictions;
• refusal to deal;
• loyalty rebates;
• data-related exclusionary practices.

The board should ask:

Does this commercial decision merely reflect legitimate competition, or is it likely to exclude equally efficient competitors?

17. Competition Compliance and Digital Markets

Competition compliance has become particularly important for technology companies.

Directors should consider risks involving:

• platform self-preferencing;
• algorithmic pricing;
• data access;
• interoperability;
• app-store restrictions;
• digital advertising;
• platform parity clauses;
• exclusive arrangements;
• algorithmic coordination.

For example, if competing algorithms are programmed using common commercially sensitive information, the company should assess whether the system could facilitate coordinated outcomes.

The board should therefore treat algorithmic competition risk as a governance issue, not merely an IT issue.

18. Individual Director Liability — Important Qualification

It is important not to overstate director liability.

A director is not automatically liable simply because he or she is a director.

The legal analysis generally requires examination of:

1. whether the company committed a contravention;
2. the person's role;
3. whether the statutory requirements for individual liability are satisfied;
4. the person's involvement or responsibility;
5. whether a statutory defence is available.

This distinction is crucial.

A non-executive director who had no involvement in the relevant conduct should not automatically be equated with an executive who personally negotiated the cartel arrangement.

19. Due Diligence as a Director Defence Strategy

Directors should maintain evidence demonstrating genuine compliance efforts.

Useful evidence includes:

• competition policies;
• training records;
• compliance certifications;
• board presentations;
• legal opinions;
• competition-risk assessments;
• whistle-blower reports;
• investigation records;
• disciplinary action;
• internal audit reports.

A company that can demonstrate a functioning compliance culture is in a much stronger governance position than one that merely adopted a competition policy on paper.

20. Seven Pillars of an Effective Competition Compliance Programme

1. Board commitment

The board should establish a clear zero-tolerance approach to cartel conduct.

2. Written policy

The company should have a comprehensive competition policy.

3. Risk assessment

High-risk departments should be identified.

Usually:

• sales;
• procurement;
• marketing;
• strategy;
• M&A;
• pricing;
• senior management.

4. Training

Training should be regular and scenario-based.

5. Monitoring

The company should monitor:

• competitor communications;
• tender processes;
• pricing;
• contracts;
• trade-association activities.

6. Reporting

Employees should have confidential reporting channels.

7. Investigation and remediation

Potential violations should be promptly investigated and corrected.

21. Role of the Board of Directors

A sophisticated board should ask at least the following questions:

22. Director Liability Matrix

23. Competition Compliance and the Fiduciary Concept

The relationship can be understood through three layers:

Layer 1 — Company liability

The enterprise may face:

• monetary penalties;
• behavioural directions;
• investigation;
• reputational damage;
• litigation.

Layer 2 — Individual liability

Responsible individuals may face consequences where the statutory requirements for individual liability are satisfied.

Layer 3 — Corporate governance liability

Directors may also face questions regarding whether they exercised:

• due care;
• diligence;
• independent judgment;
• good faith; and
• proper oversight.

Thus:

Competition law → Corporate conduct → Management conduct → Director oversight

24. Practical Competition Compliance Programme for Directors

A company can implement the following framework:

Board Competition Policy

↓

Annual Competition Risk Assessment

↓

Mandatory Director & Employee Training

↓

High-Risk Transaction Review

↓

Competitor-Contact Protocol

↓

Tender Compliance Programme

↓

Trade-Association Rules

↓

Whistle-Blower Mechanism

↓

Internal Investigation

↓

Board Reporting

↓

Periodic Compliance Audit

This converts competition law from a purely legal requirement into a corporate-governance system.

25. Key Lessons from the Case Law

The cases collectively establish several important principles:

First

Competition law is concerned with substance rather than labels.

Second

Competitor coordination can create severe liability even without a traditional written cartel contract.

Third

Tender processes require particularly strong compliance controls.

Fourth

Competition investigations can reveal broader patterns of conduct than the original complaint might suggest, as illustrated by the principles discussed in Excel Crop Care and Cadila Healthcare.

Fifth

Directors cannot treat competition compliance as solely a matter for junior employees.

Sixth

Individual liability must nevertheless be determined according to the statutory framework and the person's actual responsibility; mere designation as a director is not enough.

Seventh

An effective compliance programme is fundamentally a risk-management and corporate-governance mechanism.

26. Conclusion

Director duties and competition compliance are closely interconnected.

The Competition Act, 2002 establishes substantive restrictions against anti-competitive agreements, abuse of dominance and problematic combinations. The Companies Act, 2013 imposes governance duties on directors concerning good faith, care, diligence and independent judgment.

Accordingly, directors should not merely ask:

"Is the company complying with competition law?"

They should ask:

"What systems have we established to ensure that the company, its executives and employees comply with competition law?"

The distinction is important.

A strong competition-compliance culture requires board-level supervision, employee training, competitor-contact controls, tender safeguards, M&A review, information-exchange restrictions, whistle-blower mechanisms and prompt investigation of suspected violations.

The Indian jurisprudence, particularly Excel Crop Care, together with SAIL, Cadila Healthcare and Rajasthan Cylinders, demonstrates that competition enforcement is capable of examining the actual commercial conduct underlying corporate decisions.

Therefore, the modern director's responsibility is not simply to avoid personally participating in a cartel. It is to exercise reasonable oversight and establish an effective competition-compliance architecture capable of preventing, detecting and responding to anti-competitive conduct.